Egle Therapeutics
Operator of a biotechnology company intended to develop immunotherapies for oncology and autoimmune diseases. The company develops a proprietary Treg (T cells) modulating drug portfolio against a larg...
Valuation
$0
Share Price
N/A
Total Raised
$47.8M
Last Round
N/A